Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stewart

Showing results (1161-1170 of 1,171) with videos related to

Pageof 118
Sort By:
Clinical Genitourinary Cancer|May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology SubtypesDimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
BJU International|October 1, 2021
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancerDimitrios Makrakis, Rafee Talukder, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|January 26, 2022
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-GuerinRafee Talukder, Dimitrios Makrakis, Leonidas N Diamantopoulos, et al.
BJU International|February 8, 2021
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomesStepan M Esagian, Ali Raza Khaki, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|September 26, 2022
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial CarcinomaRafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, et al.
Acta Neuropathologica|November 23, 2013
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working GroupNicholas G Gottardo, Jordan R Hansford, Jacqueline P McGlade, et al.
Clinical Genitourinary Cancer|July 1, 2022
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaDimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, et al.
Drug Discovery Today. Disease Models|August 12, 2024
Genome Wide Conditional Mouse Knockout ResourcesC Kaloff, K Anastassiadis, A Ayadi, et al.
Science (New York, N.Y.)|November 7, 2015
Early MAVEN Deep Dip campaign reveals thermosphere and ionosphere variabilityS Bougher, B Jakosky, J Halekas, et al.
Science (New York, N.Y.)|November 7, 2015
MAVEN observations of the response of Mars to an interplanetary coronal mass ejectionB M Jakosky, J M Grebowsky, J G Luhmann, et al.
Pageof 118

Showing results (1161-1170 of 1,171) with videos related to

Sort By:
Pageof 118
Clinical Genitourinary Cancer|May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology SubtypesDimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
BJU International|October 1, 2021
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancerDimitrios Makrakis, Rafee Talukder, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|January 26, 2022
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-GuerinRafee Talukder, Dimitrios Makrakis, Leonidas N Diamantopoulos, et al.
BJU International|February 8, 2021
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomesStepan M Esagian, Ali Raza Khaki, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|September 26, 2022
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial CarcinomaRafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, et al.
Acta Neuropathologica|November 23, 2013
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working GroupNicholas G Gottardo, Jordan R Hansford, Jacqueline P McGlade, et al.
Clinical Genitourinary Cancer|July 1, 2022
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaDimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, et al.
Drug Discovery Today. Disease Models|August 12, 2024
Genome Wide Conditional Mouse Knockout ResourcesC Kaloff, K Anastassiadis, A Ayadi, et al.
Science (New York, N.Y.)|November 7, 2015
Early MAVEN Deep Dip campaign reveals thermosphere and ionosphere variabilityS Bougher, B Jakosky, J Halekas, et al.
Science (New York, N.Y.)|November 7, 2015
MAVEN observations of the response of Mars to an interplanetary coronal mass ejectionB M Jakosky, J M Grebowsky, J G Luhmann, et al.
Pageof 118